(Total Views: 364)
Posted On: 06/26/2018 6:49:24 AM
Post# of 4488
$AYTU Free Pre-Market Technical Pulse on AVEO Pharma and Three More Biotech Stocks
LONDON, UK / ACCESSWIRE / June 25, 2018 / If you want a free Stock Review on AVEO sign up now at www.wallstequities.com/registration. In today's pre-market research reports, WallStEquities.com monitors AVEO Pharmaceuticals Inc. (NASDAQ: AVEO), Aytu BioScience Inc. (NASDAQ: AYTU), Bellicum Pharmaceuticals Inc. (NASDAQ: BLCM), and BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX). These stocks are part of the Biotech industry, which focuses on novel drug development and clinical research aimed at treating diseases and medical conditions. As per Investopedia, biotechnology companies are almost always unprofitable (some suggest that the distinction between "biotech" and "pharmaceutical" company lies in profitability), and many have no real revenue at all. All you have to do is sign up today for this free limited time offer by clicking the link below.
www.wallstequities.com/registration
Aytu BioScience
Englewood, Colorado-based Aytu BioScience Inc.'s stock finished 6.02% lower at $0.31 with a total trading volume of 489,279 shares. The stock is trading below their 50-day moving average by 23.44%. Shares of the Company, which focuses on developing and commercializing novel products in the field of urology in the US, has an RSI of 36.83.
On June 13th, 2018, Aytu BioScience announced that it has exclusively licensed Zolpimistâ„¢ (zolpidem tartrate oral spray) in the US and Canada. Zolpimist is an FDA-approved, proprietary, oral spray formulation of zolpidem tartrate and is indicated for the short-term treatment of insomnia characterized by difficulties with sleep initiation. Download our actionable research report on AYTU at:
www.wallstequities.com/registration/?symbol=AYTU
LONDON, UK / ACCESSWIRE / June 25, 2018 / If you want a free Stock Review on AVEO sign up now at www.wallstequities.com/registration. In today's pre-market research reports, WallStEquities.com monitors AVEO Pharmaceuticals Inc. (NASDAQ: AVEO), Aytu BioScience Inc. (NASDAQ: AYTU), Bellicum Pharmaceuticals Inc. (NASDAQ: BLCM), and BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX). These stocks are part of the Biotech industry, which focuses on novel drug development and clinical research aimed at treating diseases and medical conditions. As per Investopedia, biotechnology companies are almost always unprofitable (some suggest that the distinction between "biotech" and "pharmaceutical" company lies in profitability), and many have no real revenue at all. All you have to do is sign up today for this free limited time offer by clicking the link below.
www.wallstequities.com/registration
Aytu BioScience
Englewood, Colorado-based Aytu BioScience Inc.'s stock finished 6.02% lower at $0.31 with a total trading volume of 489,279 shares. The stock is trading below their 50-day moving average by 23.44%. Shares of the Company, which focuses on developing and commercializing novel products in the field of urology in the US, has an RSI of 36.83.
On June 13th, 2018, Aytu BioScience announced that it has exclusively licensed Zolpimistâ„¢ (zolpidem tartrate oral spray) in the US and Canada. Zolpimist is an FDA-approved, proprietary, oral spray formulation of zolpidem tartrate and is indicated for the short-term treatment of insomnia characterized by difficulties with sleep initiation. Download our actionable research report on AYTU at:
www.wallstequities.com/registration/?symbol=AYTU
(0)
(0) Engineer by trade & Swing Trader at Heart!
Join Webull today and get up to 75 #FREE stocks!
Get started >> Register with my referral link now>> JOIN HERE NOW
CLICK TO SEE --> Engineer, Design,& Build Packaging Equipment
Join Webull today and get up to 75 #FREE stocks!
Get started >> Register with my referral link now>> JOIN HERE NOW
CLICK TO SEE --> Engineer, Design,& Build Packaging Equipment
Scroll down for more posts â–¼
